Andreas Mund

Andreas Mund serves as an Associate Professor at the Novo Nordisk Foundation Center for Protein Research, which operates within the Faculty of Health and Medical Sciences at the University of Copenhagen. As a key member of the Mann Group led by Matthias Mann, he contributes to cutting-edge research in proteomics with significant clinical applications. His work bridges advanced proteomic technologies with cancer biology investigations.

Dr. Mund's research program focuses on clinical proteomics with particular emphasis on cancer mechanisms. His investigations span epigenetics, genome stability, DNA damage response and repair pathways, chromatin structure and function, and tissue regeneration processes in cancer contexts. He has pioneered applications of deep visual proteomics that enable spatially resolved proteome analysis within complex tumor microenvironments. His work integrates multiplexed imaging with advanced mass spectrometry to reveal previously inaccessible biological insights.

His publication record from 2024-2025 demonstrates a strong trajectory in applying proteomic innovations to cancer research challenges. His work shows consistent advancement in organoid modeling techniques, tumor microenvironment characterization, and translational applications of proteomics. Notably, his research has successfully demonstrated how deep visual proteomics can reveal in vivo-like phenotypes in transplanted organoids, providing more physiologically relevant models for cancer research.

Dr. Mund maintains active international collaborations across multiple continents, as evidenced by his co-authorship on papers with researchers from diverse institutions worldwide. His work has received significant attention in the scientific community with citations across multiple platforms including Scopus, Mendeley, and social media discussions by researchers. His publications have been featured in news outlets and have generated substantial academic discussion.